O CD-31 tamén se expresa en cetos tumores, como o hemanxioendotelioma epitelioide, hemanxiotelioma de tipo sarcoma epitelioide, outros tumores vasculares, tumores malignos histiocíticos e plasmocitomas. Atópase raramente nalgúns sarcomas, como o de Kaposi[7][8] e carcinomas.
En inmunohistoquímica, o CD31 utilízase principalmente para demostrar a presenza de células endoteliais en preparacións de tecidos histolóxicos. Isto pode ser de axuda para avaliar o grao de anxioxénese tumoral, que pode implicar un crecemento rápido do tumor. As células endoteliais malignas tamén poden xeralmente conservar este antíxeno, polo que a inmunohistoquímica do CD31 pode tamén utilizarse para demostrar a presenza de anxiomas e anxiosarcomas. Tamén se pode demostrar a súa presenza en linfomas linfocíticos pequenos e linfomas linfoblásticos, aínda que se dispón de marcadores máis específicos para esas doenzas.[9]
↑Gumina RJ, Kirschbaum NE, Rao PN, vanTuinen P, Newman PJ (1996). "The human PECAM1 gene maps to 17q23". Genomics34 (2): 229–32. PMID8661055. doi:10.1006/geno.1996.0272.
↑Xie Y, Muller WA (1996). "Fluorescence in situ hybridization mapping of the mouse platelet endothelial cell adhesion molecule-1 (PECAM1) to mouse chromosome 6, region F3-G1". Genomics37 (2): 226–8. PMID8921400. doi:10.1006/geno.1996.0546.
Newman PJ, Newman DK (2004). "Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology.". Arterioscler. Thromb. Vasc. Biol.23 (6): 953–64. PMID12689916. doi:10.1161/01.ATV.0000071347.69358.D9.
Wong MX, Jackson DE (2004). "Regulation of B cell activation by PECAM-1: implications for the development of autoimmune disorders.". Curr. Pharm. Des.10 (2): 155–61. PMID14754395. doi:10.2174/1381612043453504.
Stockinger H, Gadd SJ, Eher R; et al. (1991). "Molecular characterization and functional analysis of the leukocyte surface protein CD31.". J. Immunol.145 (11): 3889–97. PMID1700999.
Kirschbaum NE, Gumina RJ, Newman PJ (1995). "Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain.". Blood84 (12): 4028–37. PMID7994021.
Tang DG, Chen YQ, Newman PJ; et al. (1993). "Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium.". J. Biol. Chem.268 (30): 22883–94. PMID8226797.
Behar E, Chao NJ, Hiraki DD; et al. (1996). "Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease.". N. Engl. J. Med.334 (5): 286–91. PMID8532023. doi:10.1056/NEJM199602013340502.
Almendro N, Bellón T, Rius C; et al. (1997). "Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization.". J. Immunol.157 (12): 5411–21. PMID8955189.
Jackson DE, Ward CM, Wang R, Newman PJ (1997). "The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling.". J. Biol. Chem.272 (11): 6986–93. PMID9054388. doi:10.1074/jbc.272.11.6986.
Coukos G, Makrigiannakis A, Amin K; et al. (1999). "Platelet-endothelial cell adhesion molecule-1 is expressed by a subpopulation of human trophoblasts: a possible mechanism for trophoblast-endothelial interaction during haemochorial placentation.". Mol. Hum. Reprod.4 (4): 357–67. PMID9620836. doi:10.1093/molehr/4.4.357.
Cao MY, Huber M, Beauchemin N; et al. (1998). "Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases.". J. Biol. Chem.273 (25): 15765–72. PMID9624175. doi:10.1074/jbc.273.25.15765.
Ma L, Mauro C, Cornish GH, Chai JG, Coe D, Fu H, Patton D, Okkenhaug K, Franzoso G, Dyson J, Nourshargh S, Marelli-Berg FM. (2010). "Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance.". PNAS107 (45): 19461–6. PMID20978210. doi:10.1073/pnas.1011748107.